JP Morgan Upgrades G1 Therapeutics to Neutral, Raises Price Target to $10
JP Morgan analyst Anupam Rama upgrades G1 Therapeutics (NASDAQ:GTHX) from Underweight to Neutral and raises the price target from $7 to $10.
EF Hutton Initiates Coverage On G1 Therapeutics with Buy Rating, Announces Price Target of $35
EF Hutton analyst Tony Butler initiates coverage on G1 Therapeutics (NASDAQ:GTHX) with a Buy rating and announces Price Target of $35.
G1 Therapeutics Reveals An Early Cut Data From Bladder Cancer Trial
G1 Therapeutics Inc (NASDAQ:GTHX) provided an initial update on the PRESERVE 3 Phase 2 study of first-line platinum-based chemotherapy…
Needham Maintains Buy on G1 Therapeutics, Lowers Price Target to $31
Needham analyst Gil Blum maintains G1 Therapeutics (NASDAQ:GTHX) with a Buy and lowers the price target from $32 to $31.
Reported Late Wednesday, G1 Therapeutics Provides Initial Results From Phase 2 Mechanism Of Action Trial In Early-Stage Triple Negative Breast Cancer Show That A Single Dose Of Trilaciclib Favorably Alters The Tumor Microenvironment
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today provided initial results from a 24 patient Phase 2 mechanism of action (MOA) trial showing favorable alterations in the tumor
Nasdaq Down 0.5%; Clearfield Shares Spike Higher
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday.
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday’s Mid-Day Session
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers IVERIC bio (NASDAQ:ISEE) shares increased by 26.7% to $21.84 during Friday’s regular session. As of 12:30 EST,…
Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.
Reported Late Thursday, G1 Therapeutics Announces Pricing Of $50.05M Public Offering Of 7.7M Shares Of Common Stock At A Price Of $6.50/Share
G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today announced the pricing of an underwritten public offering of 7,700,000 shares of its common stock at a public offering price